🎯 #ESMO26 | What if we treated the molecular profile, not just the tumor site? Tumor agnostic therapies are redefining precision oncology, making comprehensive genomic profiling and biomarkerdriven decisions increasingly important. The challenge: translating molecular findings into meaningful clinical benefit. #PrecisionMedicine
#Oncology

Watch here the complete webinar:

https://oncologypro.esmo.org/webinars/esmo-therapeutic-landscapes-webinar-tumour-agnostics-2026